Success Metrics

Clinical Success Rate
84.4%

Based on 76 completed trials

Completion Rate
84%(76/90)
Active Trials
41(25%)
Results Posted
12%(9 trials)
Terminated
14(8%)

Phase Distribution

Ph phase_3
1
1%
Ph phase_4
1
1%
Ph phase_2
2
1%
Ph early_phase_1
2
1%
Ph phase_1
5
3%
Ph not_applicable
48
29%

Phase Distribution

7

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution59 total trials
Early Phase 1First-in-human
2(3.4%)
Phase 1Safety & dosage
5(8.5%)
Phase 2Efficacy & side effects
2(3.4%)
Phase 3Large-scale testing
1(1.7%)
Phase 4Post-market surveillance
1(1.7%)
N/ANon-phased studies
48(81.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.8%

76 of 99 finished

Non-Completion Rate

23.2%

23 ended early

Currently Active

41

trials recruiting

Total Trials

167

all time

Status Distribution
Active(49)
Completed(76)
Terminated(23)
Other(19)

Detailed Status

Completed76
Recruiting33
unknown19
Terminated14
Withdrawn9
Active, not recruiting8

Development Timeline

Analytics

Development Status

Total Trials
167
Active
41
Success Rate
84.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.4%)
Phase 15 (8.5%)
Phase 22 (3.4%)
Phase 31 (1.7%)
Phase 41 (1.7%)
N/A48 (81.4%)

Trials by Status

unknown1911%
withdrawn95%
completed7646%
terminated148%
recruiting3320%
active_not_recruiting85%
enrolling_by_invitation21%
not_yet_recruiting64%

Recent Activity

Clinical Trials (167)

Showing 20 of 167 trialsScroll for more
NCT04680117Not Applicable

Defining the Severe Paediatric Asthma Endotype

Completed
NCT04451980

The HIV, Adipose Tissue Immunology, and Metabolism Study

Completed
NCT07566780

Cell-based Non-invasive Prenatal Test Workflow

Not Yet Recruiting
NCT06074133

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Active Not Recruiting
NCT05051722

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Recruiting
NCT03776474

Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children

Completed
NCT04703114Not Applicable

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

Completed
NCT05847855

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Recruiting
NCT07134491

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Recruiting
NCT01374620Phase 1

Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel

Completed
NCT03648918

Genetics Of Autoimmunity In Type I Diabetes

Recruiting
NCT05716022

Hiatal Hernia and Pulmonary Involvement

Completed
NCT07177885

Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans

Recruiting
NCT06510868

Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy

Recruiting
NCT01874769

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Completed
NCT03830320Phase 1

Positron Emission Tomography (PET) Imaging of Thrombosis

Recruiting
NCT06521502

The APS Phenotyping Study

Recruiting
NCT02382601

Longitudinal Study of Intra-Uterine Growth Restriction

Recruiting
NCT01173341

Cardiotoxicity of Cancer Therapy (CCT)

Enrolling By Invitation
NCT06804057

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
167